DevelRx is a R&D-based consultancy organisation providing strategic and scientific support on the discovery, safety, toxicity and regulatory approval of molecules that enter the central nervous system (CNS), ranging from traditional CNS drug candidates to psychedelics and cannabinoids and peripherally-acting agents that may penetrate the brain.
The Leadership Team at DevelRx is composed of senior professionals with over 30 years of experience of the pharmaceutical industry and exemplary academic credentials. Our consultants have proven track-records in drug discovery, global drug development and registration with key roles in regulatory submissions in the USA (FDA; Food and Drug Administration), UK (MHRA; Medicines and Healthcare products Regulatory Agency), Europe (EMA; European Medicines Agency), Canada and Japan.
DevelRx’s experts have provided key pre-clinical support for 16 new drug registrations in the therapeutic indications of attention deficit hyperactivity disorder, binge-eating disorder, epilepsy, schizophrenia, Parkinson’s disease, obesity, migraine, opiate withdrawal and opiate-induced constipation.
Our areas of expertise include the pharmacology of drugs of abuse. We are globally acknowledged experts on assessing abuse potential of new drugs and have performed abuse/dependence evaluations for more than 50 clients. We design abuse testing experiments tailored to the unique pharmacological profile of each new drug, supervise safety testing and prepare the regulatory submission. Our services include robust, quantitative and reproducible chemical similarity assessment of new compounds to drugs with known or likely abuse potential including Tanimoto analysis (with Scitegrity) and 8-factor analyses of abuse potential. Our expertise and advice has enabled our clients to achieve optimal drug scheduling for their compounds. We also offer abuse potential assessment waiver submissions.
Further information on our services can be found on our website.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Biocity, Nottingham,ng1 1gf,united Kingdom
- Industry
- Business Consulting And Services
- NAICS
-
Management, Scientific, and Technical Consulting ServicesManagement Consulting ServicesOther Scientific and Technical Consulting ServicesOther Management Consulting Services
- Website
- https://develrx.com/
- Keywords
- Scientific and Strategic Support for Research Stage Pharmaceutical Projects, Design and Preparation of Experimental Protocols, Regulatory Support for Drugs in Clinical Development, Participation in Scientific and Clinical Advisory Board Meetings, Medical Education, Expert Witness Work, Intellectual Property, CNS active drugs, Psychedelics, Cannabinoids, Pharmaceuticals, Drug safety, 8-factor analyses, ADHD, Psychiatric and Neurological Disorders, Obesity and Metabolic Disorders, Binge-Eating Disorder, Drug Abuse Evaluation, Abuse and dependence assessment, Dietary ingredients and supplements.
- HQ
- Nottingham
Develrx Ltd Questions
Develrx Ltd's website is https://develrx.com/
Develrx Ltd's LinkedIn profile is https://uk.linkedin.com/company/develrx-ltd
Develrx Ltd has
3 employees.
View email and phone details for 3
employees at Develrx Ltd.
Develrx Ltd's industry is
Business Consulting and Services
Develrx Ltd's top competitors are
Really Clever,
Freenome Limited,
Agility Life Sciences,
Intelligent Omics Ltd,
Selentus Science Limited,
Nuvision Biotherapies Ltd,
Biomedha,
Platelet Services,
Biopharma Stability Testing Laboratory Limited,
Myconeos Limited.
Develrx Ltd's categories are Business Consulting and Services
Develrx Ltd's founding year is 2020
